First-in-human data of ALLO-501 and ALLO-647 in relapsed/refractory large B-cell or follicular lymphoma (R/R LBCL/FL): ALPHA study.

被引：0

作者：

Neelapu, Sattva Swarup

Munoz, Javier

Locke, Frederick Lundry

Miklos, David Bernard

Brown, Robert

McDevitt, Jennifer T.

Mardiros, Armen

Demirhan, Eren

Konto, Cyril

Tees, Michael Timothy

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[2] Banner MD Anderson Canc Ctr, Gilbert, AZ USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[4] Stanford Univ, Sch Med, Stanford, CA USA

[5] Allogene Therapeut, San Francisco, CA USA

[6] Colorado Blood Canc Inst, Sarah Cannon Res Inst, Denver, CO USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8002

引用

页数：2